Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larissa Mulka

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|August 10, 2022
The changing face of monkeypoxLarissa Mulka, Jackie Cassell
Journal of Public Health (Oxford, England)|July 19, 2018
Strategies to reduce the burden of HPV disease in HIV-positive men who have sex with menMaximilian Johnson, Larissa Mulka, Daniel Richardson
Sexually Transmitted Infections|February 20, 2016
Raltegravir-based HIV postexposure prophylaxis (PEP) in a real-life clinical setting: fewer drug-drug interactions (DDIs) with improved adherence and tolerabilityLarissa Mulka, David Annandale, Claire Richardson, et al.
International Journal of STD & AIDS|December 17, 2020
HIV-1 transmitted drug resistance in Brighton, UK, from 2014 to 2020Daniel Richardson, Colin Fitzpatrick, Luke Parkes, et al.
AIDS (London, England)|December 8, 2022
Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRISHolly Coltart, Kate El Bouzidi, Larissa Mulka, et al.
Practical Neurology|December 18, 2025
Neurosyphilis-related myelitisMilo Patrick Delaney, Shiran Ajith Paranavitane, Larissa Mulka, et al.
The Journal of Infection|February 2, 2017
Real-world persistence with antiretroviral therapy for HIV in the United Kingdom: A multicentre retrospective cohort studyJoseph M Lewis, Colette Smith, Adele Torkington, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|August 10, 2022
The changing face of monkeypoxLarissa Mulka, Jackie Cassell
Journal of Public Health (Oxford, England)|July 19, 2018
Strategies to reduce the burden of HPV disease in HIV-positive men who have sex with menMaximilian Johnson, Larissa Mulka, Daniel Richardson
Sexually Transmitted Infections|February 20, 2016
Raltegravir-based HIV postexposure prophylaxis (PEP) in a real-life clinical setting: fewer drug-drug interactions (DDIs) with improved adherence and tolerabilityLarissa Mulka, David Annandale, Claire Richardson, et al.
International Journal of STD & AIDS|December 17, 2020
HIV-1 transmitted drug resistance in Brighton, UK, from 2014 to 2020Daniel Richardson, Colin Fitzpatrick, Luke Parkes, et al.
AIDS (London, England)|December 8, 2022
Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRISHolly Coltart, Kate El Bouzidi, Larissa Mulka, et al.
Practical Neurology|December 18, 2025
Neurosyphilis-related myelitisMilo Patrick Delaney, Shiran Ajith Paranavitane, Larissa Mulka, et al.
The Journal of Infection|February 2, 2017
Real-world persistence with antiretroviral therapy for HIV in the United Kingdom: A multicentre retrospective cohort studyJoseph M Lewis, Colette Smith, Adele Torkington, et al.
Pageof 1